chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Myalgia, Arthralgia, NauseaVomiting, lower abdominal pain Per nursing report: "took 2nd dose of Moderna vaccine yesterday. C/o last night [2/3] having achy knees, hips,neck and back pain, nausea and lower abdominal pain with low grade fever."
tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for COVID). At the time of the report, COVID-19 (tested positive for COVID) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Pt reported difficulty breathing and felt like throat swelling at 1225. Vaccine given at 1212. Epi pen given at 1226. O2 was 96% on room air at the lowest, BP 162/86, HR 107. Epipen lotG210102X. Pt evaluated by doctor, lungs CTA, throat no edema noted per doctor. Pt reported feeling better after Epi injection. RA up to 98%.  ***
Pressure in back; spider vein; capillaries  that burst; red arm; petechiae outburst; muscle twitch; Stiff neck; Hearing issue; missed second dose; Head numbness; covid arm; brain fog; fatigue; swollen lymph; joint pain on left knee,; arm pain/Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm) and PETECHIAE (petechiae outburst) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), PRODUCT DOSE OMISSION ISSUE (missed second dose), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache). The patient was treated with DOXYCYCLINE for Petechiae, at an unspecified dose and frequency; METHYLPREDNISOLONE for Swollen lymph nodes, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries  that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antiphospholipid antibodies: positive (Positive) Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Pep scan came normal. No concomitant medications were reported by the reporter. Treatment mediations includes Advil and 2 compression devices were used.
Next day post vax, the pt broke out with rash and localized swelling on left leg only. Small circular welts.
A report from a consumer via MHRA concerns a male patient of unknown age. Concomitant medications included dihydrocodeine, paracetamol, and sertraline. The patient received an unspecified influenza virus vaccine (without reported manufacturer, brand name, route of administration, or batch identifier) and Pneumococcal polysaccharide vaccine during 2013. On the same day that he received these vaccinations he experienced headache and vomiting. Patient went to doctors the following day and was sent to hospital and spent 4 days there. All symptoms occur every 2 weeks. The day after the vaccinations, he developed diarrhea, difficulty sleeping, and sweat rash. Felt like an infection. At the time of reporting, diarrhoea, difficulty sleeping, sweat rash, vomiting, and headache were ongoing. Reporter considered the events to be serious based on hospitalization and as important medical events.
This case meets vaccine breakthrough criteria .  SXS INCLUDE HEADACHE, BODY ACHES, LOSS OF TAST, FATIGUE
Joint pain beginning the morning after my second vaccine. Later in the day additional joint aching, chills, fever, and a headache. Side effects required a day off of work. 2nd day after vaccine most aching was gone except for less severe aching in hips and knees. Day 3 all side effects gone. No pain at injection site at any point. Mild bruising at injection site. No symptoms or pain after 1st vaccine.
Patient presented to ED for shortness of breath and dyspnea on exertion. He was attributing it to getting the COVID vaccine. Patient had gotten the 2nd dose of the Pfizer vaccine on 3/11/21. He reported that shortness of breath started about 3 weeks prior after receiving the first vaccine dose. Patient reported  that he received the COVID vaccine at his place of residence and thought it was a CVS that provided the vaccinations. Patient has a PMH of cardiomyopathy and was found to be in atrial flutter in the ED. Cardiology service was consulted and plan currently is to try to cardiovert the patient.  History of obesity, ETOH abuse, known RBBB, dilated NICM with HFrEF (has been out of meds) hx of c
PATIENT FEELING DIFFICULTY IN BREATHING, CHEST CONGESTION AND COUGHING A LOT AFTER 2 DAYS OF FEVER.
INJECTION SITE STARTED TO ITCH; ARM SWELLED AND HAS BECOME SWOLLEN AND PAINFUL. STILL SWOLLEN AND PAINFUL TODAY, BUT IMPROVING.
Baby cried for 5 days- very fussy.  Had jerky-spastic type movements that started on Sat. am
Patient received the vaccine on 10/13.  On 10/16, the patient returned to the pharmacy and he had just been to prompt care for decreased ROM of the right arm.  The doctor prescribed a course of steroids.  On 10/30, the patient returned to the pharmacy to let me know he had full ROM in the right arm.
Chills starting at midnight, lasting until 10:00 pm the following day Nausea beginning at 3:00 am, vomited at 10:00 am. Continued to feel nauseous until I went to be that night Body aches from midnight until following evening
I noticed I had a lump in opposite armpit than injection site. I went to urgent care and received a mammogram and ultrasound. No explanation of lump. Doctor visit scheduled for next month. Mild discomfort in under arm. Severe pain in left shoulder after vaccine.
27FEB pt seen for routine PE & 2nd vax; MD noticed a sl head lag but was not concerned; 9APR Pt was seen again because dad was concerned about developmental delay; MD observed hypertonia & absence of DTR's; 21APR dx werdnig-hoffman paralysi
102 fever, strong kidney and lymph node pain, and bed-soaking sweat that occurred 4-6am the morning after.
Headache; This is a spontaneous case, initially received from non-health professional (consumer) via Agency (reference number: SEQ19-06509) on 11-Nov-2019, concerning a 72-year-old, female patient.   The patient's historical conditions included gallbladder operation, surgical operations for tonsil and removed part of the liver due to non-cancerous tumours.   The patient's current conditions included diverticulitis and colitis.  The patient's concomitant medications included Synthroid (levothyroxine) and methylamine, both for an unknown indication and occasionally medication for colitis.  The patient received Shingles shot (herpes zoster vaccine) reported as one month ago, for an unknown indication.  On 07-Nov-2019, the patient was administered with administered Fluad (TIV) [influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number and expiration date: not reported] for influenza prophylaxis.   On 10-Nov-2019, the patient woke up with headache. It was reported the patient generally did not have headaches.  On an unspecified date in Nov-2019, reported as at noon, the patient received treatment medication Aspirin (acetylsalicylic acid), dose reported as 2, units were not specified.  On 11-Nov-2019, the outcome of headache was not resolved.  The reporter assessed the case as non-serious. The reporter did not provide causality assessment to Fluad (TIV).  Non-significant follow-up reported by other non-health professional from Agency [reference number: SEQ19-06817] on 12-Dec-2019: Additional reference number added. No changes in narrative.  Company comment: The event of headache was considered related to Fluad (TIV) .; Sender's Comments: Company comment: The event of headache was considered related to Fluad (TIV) .
she had an extreme reaction to her skin and is completely covered with red bumps all over her body; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (she had an extreme reaction to her skin and is completely covered with red bumps all over her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Spikevax. Past adverse reactions to the above products included No adverse event with Spikevax.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (she had an extreme reaction to her skin and is completely covered with red bumps all over her body). At the time of the report, RASH ERYTHEMATOUS (she had an extreme reaction to her skin and is completely covered with red bumps all over her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was reported.  It was unknown patient Received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No treatment medication information was reported.   Reporter did not allow further contact
About 5 mins after injection while sitting, pt became stiff and pale "fainted" mom said responded well to stimuli felt weak shakey and "weak stomach" No nausea or vomiting for about 1/2 hr. 5/22/02-24hr stomach virus with vomiting X 2. Mother and daughter have same sp.
whole body was extreamly ache; ache felt it was in my bones; headache; Eyeballs sore/tender; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 19Jan2022 (Lot number: FJ1614) at the age of 53 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Time: 12:00, LOT: FJ1611, Arm right), administration date: 29Dec2021, for COVID-19 immunization, reaction(s): "Nausea", "Musculoskeletal stiffness", "Pain", "Chest discomfort", "Arthralgia", "Lymph node pain", "Lymphedenopathy". The following information was reported: PAIN (non-serious) with onset 20Jan2022 01:00, outcome "recovered" (2022), described as "whole body was extreamly ache"; BONE PAIN (non-serious) with onset 20Jan2022 01:00, outcome "recovered" (2022), described as "ache felt it was in my bones"; HEADACHE (non-serious) with onset 20Jan2022 01:00, outcome "recovered" (2022), described as "headache"; EYE PAIN (non-serious) with onset 20Jan2022 01:00, outcome "recovered" (2022), described as "Eyeballs sore/tender". Therapeutic measures were not taken as a result of pain, bone pain, headache, eye pain. Additional information: The night after the patient received the second shot and wake up at 1 am, whole body was extremely achy and the ache felt like it was in the bones not in muscles. The patient also had a headache and the eyeballs hurt, when touched the eyelid, the eyes felt tender. No follow-up attempts are possible. No further information is expected.
I have had lymphedema in my left leg for over 45 years and 3 days after the first COVID 19 shot in the right arm, I got swelling in my right leg now and it hasn't gone away since.
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent (manufacturer unknown). On 01-SEP-2017, the patients were vaccinated with improperly stored PROQUAD (dose, frequency and route were unknown, lot # M044720, expiration date: 07-MAY-2018, lot # N013863, expiration date: 31-OCT-2018) for prophylaxis. Administered vaccine experienced the temperature excursion of -14 Celsius degree to -10 Celsius degree (-14.2 Celsius degree) for 6 hours. There was no previous temperature excursion. Data logger was involved. No adverse effects reported. No product quality complaint (PQC) was involved. All telephone attempts on 10-OCT-2017 to obtain follow up information have been unsuccessful. Follow up information has been received from an other reporter concerning a 4 year old patient. On 08-SEP-2017, the patient vaccinated with improperly stored PROQUAD (dose, frequency and route were unknown, lot # N013863, expiration date: 31-OCT-2018) for prophylaxis. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA002186: US-009507513-1709USA002098.
Menstrual cycle arrived one week early.; This is a spontaneous report from a contactable healthcare professional (patient). This 44-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EN5318) via unspecified route of administration in the left arm on 05Feb2021 at 12:00 (at the age of 44-years-old) as a single dose for COVID-19 immunization. The patient had no medical history and was not allergic to medications, foods or other products. The patient did not have COVID-19 prior to vaccination. Concomitant medications included birth control pills from an unknown date for an unknown indication. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that her menstrual cycle arrived one week early on 09Feb2021; further stating her period was not supposed to start until 16Feb(2021). The event was reported as non-serious and did not require hospitalization. No treatment was provided for the event. The outcome of menstrual cycle arrived one week early was recovering. It was also reported the patient had not been tested for COVID-19 since vaccination.
fainted; became sweaty; This case was reported by a consumer via media and described the occurrence of fainting in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, several hours after receiving Shingrix, the patient experienced fainting (serious criteria GSK medically significant) and sweating. On an unknown date, the outcome of the fainting and sweating were unknown.   It was unknown if the reporter considered the fainting and sweating to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication. The patient received 1st dose of Shingrix and few hours later became sweaty and fainted. The patient wanted to know that would the 2nd dose produce the same reaction, as he/she had been scheduled to get 2nd dose 19th March 2021 and also how long could he/she wait before getting the 2nd vaccine as COVID vaccines were here now.
This spontaneous report was received from a registered nurse, and refers to a 52 years old male patient, positive to human inmunodeficiency virus. The patient's medical history and concomitant medications were not provided. On 08-AUG-2017, the patient was vaccinated with the second dose of PNEUMOVAX 23, lot number M042324, expiration date 10-JUN-2018, for prophylaxis (route of administration was not reported); 8 years after receipt of his first dose, in approximately August 2009. The patient also received MENACTRA (route of administration, indication, lot number and expiration date were not provided) concomitantly with the second dose of PNEUMOVAX 23. On 09-AUG-2017, the patient experienced flu-like symptoms of myalgia, fever and chills. He also reported arm pain which impaired its movement. The events resolved within 24 hours without treatment. . Assessment of the relationship of the aforementioned events to PNEUMOVAX 23 and MENACTRA was not provided. This is one of two cases received from the same source.; Sender's Comments: US-009507513-1708USA004684:
Covid 19- Long covid symptoms taste and smell hadn't fully come back trouble breathing with shortness of breath im now taking Asthma medication now.
This patient was given the COVD vaccine and then had an adverse reaction. She experienced a racing heartbeat, couldn't feel her tongue, and she had difficulty breathing. One of the pharmacists who was monitoring the patient administered an epi-pen and after 20 minutes or so the patients symptoms subsided.
While the vaccination was being administered, the needle separated from the syringe.  The nurse believes the patient received most of the dose.  The syringe was a  3mL syringe with hypodermic safety needle (lot #027225).  There was no injury to the patient, and the needle was removed without issue.
expired IPOL vaccine was administered/no AE; Initial information received on 02-Jan-2020 regarding an unsolicited valid non-serious case received from a other health professional in the.  This case was linked to 2020SA002276 (via same reporter).  It was reported that 4 years old female patient received expired Ipol vaccine /no AE(expired product administered) of vaccine IPV (VERO) [IPOL].  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On 02-Jan-2020, the patient received a 0.5 ml dose of suspect IPV (VERO) lot N1K921M via unknown route in the left deltoid.  It was actual medication error due to expired vaccine used.  It was also a case of off label use as it was prescribed by Medical Doctor.  At the time of this report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient mentions that he has read online that there are other people who tinnitus has gotten worse after the vaccine or they had developed tinnitus after receiving the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Patient mentions that he has read online that there are other people who tinnitus has gotten worse after the vaccine or they had developed tinnitus after receiving the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, the patient experienced TINNITUS (Patient mentions that he has read online that there are other people who tinnitus has gotten worse after the vaccine or they had developed tinnitus after receiving the vaccine). At the time of the report, TINNITUS (Patient mentions that he has read online that there are other people who tinnitus has gotten worse after the vaccine or they had developed tinnitus after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were provided. No lab data was provided by the reporter.
This patient experienced no adverse reaction.     This patient came to the clinic and was given the Jynneos vaccine without having secured the consent of his parent as patient is under 18 years of age.    Mother was present at the clinic but this nurse did not realize this patient was under the age of 18 at the time of administering the vaccination.
Patient received the covid vaccine at 2:30 pm on Wednesday , Thursday evening began with hives, which were diffuse and covered 80% of his back (based on picture) parents showed. He was given Benadryl and had no shortness of breath/chest pain, and dad reports "bumps" were improved 1 hour later, dad then gave Benadryl at 2am and the hives remained improved and by morning they were gone. No respiratory distress, shortness of breath, or throat swelling.   This morning at 11am had small start of hives and was immediately given Benadryl. No chest pain/short of breath, + tired and no fever/cough/ST No new foods/soap/lotion/detergent or items per parents.    pmhx- mom reports that when he was very young- maybe 1 year or under he had multiple vaccines given and within 2 hours had severe rage/anger and then was ok 2 hours after the vaccine. Since then receives vaccines only one at a time.   No /v/d/resp distress/abd pain/headache/st, appetite is ok, drinking well, urine output normal
Chest pain, received motrin, MRI with myocarditis, elevated troponin le els
Client had uncontrollable cough over 4 hours after vaccine. Reported difficulty breathing like someone sit on chest. Client called physician instructed to use inhaler to help with breathing. Reported being ok now.